Systemic vasculitis in childhood

Current Rheumatology Reports

Volumn 11, Issue 6, 2009, Pages 402-409

  Gedalia, Abraham ^a   Cuchacovich, Raquel ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISONE; RITUXIMAB; STEROID; THROMBOMODULIN; TUMOR NECROSIS FACTOR INHIBITOR; UROKINASE; WARFARIN;

ANAPHYLACTOID PURPURA; ANGIOGRAPHY; AORTA ARCH SYNDROME; ARTHRALGIA; CHILDHOOD; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MORBIDITY; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL CHEMOTAXIS; ONSET AGE; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; PREECLAMPSIA; PURPURIC RASH; RACE DIFFERENCE; REVIEW; SEASONAL VARIATION; SEX DIFFERENCE; SINGLE DRUG DOSE; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; THROMBOCYTE COUNT; UNSPECIFIED SIDE EFFECT; WINTER;

CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; INCIDENCE; PROGNOSIS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; VASCULITIS;

EID: 72549117636     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0059-4     Document Type: Review

References (52)

1. M.J. Dillon S. Ozen 2006 A new international classification of childhood vasculitis Pediatr Nephrol 21 1219 1222 10.1007/s00467-006-0181-8 16821024 (Pubitemid 44203444)
2. S. Ozen N. Ruperto M.J. Dillon, et al. 2006 EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides Ann Rheum Dis 65 936 941 10.1136/ard.2005.046300 1:STN:280:DC%2BD28zlsVKhtw%3D%3D 16322081
3. A. Gedalia 2004 Henoch-Schönlein purpura Curr Rheumatol Rep 6 195 202 10.1007/s11926-004-0068-2 15134598
4. E.J. Tizard M.J. Hamilton-Ayres 2008 Henoch-Schönlein purpura Arch Dis Child Ed Pract 93 1 8 10.1136/adc.2004.066035 1:STN:280: DC%2BD1c%2FlsVGisg%3D%3D (Pubitemid 351204778)
5. J.A. Mills B.A. Michel D.A. Bloch, et al. 1990 The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura Arthritis Rheum 33 1114 1121 10.1002/art.1780330521 1:STN:280: DyaK3czlvVyqtw%3D%3D 2202310
6. A.K. Shetty B.C. Dessele J.L. Ey, et al. 2000 Infantile Henoch-Schönlein purpura Arch Fam Med 9 553 556 10.1001/archfami.9.6.553 1:STN:280:DC%2BD3czhvFGksA%3D%3D 10862218
7. K.K. Lau R.J. Wayett Z. Moldoveanu, et al. 2007 Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura Pediatr Nephrol 22 2067 2072 10.1007/s00467-007- 0623-y 17943324 (Pubitemid 350090713)
8. M. Fujieda N. Oishi K. Naruse, et al. 1998 Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura Arch Dis Child 78 240 244 10.1136/adc.78.3.240 1:STN:280:DyaK1c3ns1ejsA%3D%3D 9613354
9. S. Fessatou P. Nicolaidou D. Gourgiotis, et al. 2008 Endothelin 1 levels in relation to clinical presentation and outcome of Henoch-Schönlein purpura BMC Pediatr 8 33 10.1186/1471-2431-8-33 1:CAS:528:DC%2BD1MXktVeguw%3D%3D 18764935
10. P.A. Brogan 2007 What's new in the aetiopathogenesis of vasculitis? Pediatr Nephrol 22 1083 1094 10.1007/s00467-007-0450-1 17357785
11. M. Karreman A.J. Jordan N. Bell, et al. 2009 Acute hemorrhagic edema of infancy: report of 4 cases and review of the current literature Clin Pediatr 48 323 326 10.1177/0009922808323113
12. A. Huber J. King P. McLaine, et al. 2004 A randomized, placebo-controlled trial of prednisone in early Henoch-Schönlein purpura (ISRCTN85109383) BMC Med 2 7 10.1186/1741-7015-2-7 15059282 (Pubitemid 39111871)
13. J. Ronkainen O. Koskimeies M. la-Houhala, et al. 2006 Early prednisone therapy in Henoch-Schönlein purpura: a randomized double-blind, placebo-controlled trial J Pediatr 149 241 247 10.1016/j.jpeds.2006.03.024 1:CAS:528:DC%2BD28Xns1KitL0%3D 16887443 (Pubitemid 44144490)
14. S. Singh Devidayal L. Kumar, et al. 2002 Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids Rheumatol Int 22 133 137 10.1007/s00296-002-0208-9 1:CAS:528:DC%2BD38XnvVeqtb4%3D 12172950 (Pubitemid 35002202)
15. J.I. Shin J.M. Park J.S. Lee, et al. 2006 Successful use of cyclosporine A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine Clin Rheumatol 25 759 760 10.1007/s10067-005-0066-4 16614794 (Pubitemid 44111327)
16. P.F. Weiss J.A. Feinstein X. Luan, et al. 2007 Effects of corticosteroid on Henoch-Schönlein purpura nephritis: a systematic review Pediatr 120 1079 1087 10.1542/peds.2007-0667 (Pubitemid 350085543)
17. Kawasaki Y, Suzuki J, Nozawa R, et al.: Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 2003, 785-789.
18. W. Chartapisak S. Opastirakul N. Willis, et al. 2009 Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review Arch Dis Child 94 132 137 10.1136/adc.2008.141820 1:STN:280:DC%2BD1M%2FotlOrsA%3D%3D 18701559
19. T. Lamireau L. Rebouissoux J.P. Hehunstre 2001 Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura Acta Pediatr 90 1081 1082 1:STN:280:DC%2BD3MngvV2itw%3D%3D
20. M. Shenoy M.V. Ognjanovic M.G. Coulthard 2007 Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone Pediatr Nephrol 22 1167 1171 10.1007/s00467-007-0498-y 17530298
21. Y. Kawasaki J. Suzuki N. Sakai, et al. 2003 Clinical and pathological features of children with Henoch-Schönlein nephritis: risk factors associated with poor prognosis Clin Nephrol 60 153 160 1:STN:280: DC%2BD3svmt1Ghuw%3D%3D 14524577
22. H. Narchi 2005 Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review Arch Dis Child 90 916 920 10.1136/adc.2005.074641 1:STN:280:DC%2BD2MvksVygtg%3D%3D 15871983 (Pubitemid 41232341)
23. J.W. Newberger M. Takahashi M.A. Gerber, et al. 2004 Endorsed clinical report, AAP, AHA: guidance for the clinicians in rendering pediatric care Pediatrics 114 1708 1733 10.1542/peds.2004-2182 (Pubitemid 41754943)
24. A.F. Freeman S.T. Shulman 2006 Kawasaki disease: summary of the American Heart Association Guidelines Am Fam Physicians 74 1141 1148
25. H. Yanagawa Y. Nakamura M. Yashiro, et al. 2006 Incidence of Kawasaki disease in Japan: the nationwide survey of 1999-2002 Pediatr Int 48 356 361 10.1111/j.1442-200X.2006.02221.x 16911079 (Pubitemid 44127884)
26. T. Suenaga H. Suzuki S. Shibuta, et al. 2009 Detection of multiple superantigen genes in stool of patients with Kawasaki syndrome Pediatr 155 266 270 10.1016/j.jpeds.2009.03.013 1:CAS:528:DC%2BD1MXos12qurs%3D
27. A.H. Rowley S.T. Shulman 2007 New developments in the search for etiologic agent of Kawasaki disease Curr Opin Pediatr 19 71 74 10.1097/MOP.0b013e328012720f 17224665 (Pubitemid 46114761)
28. K. Takahashi T. Oharaseki S. Naoe, et al. 2005 Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease Pediatr Int 47 305 310 10.1111/j.1442-200x.2005.02049.x 15910456 (Pubitemid 40827508)
29. H. Senzaki 2006 The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases Arch Dis Child 91 847 851 10.1136/adc.2005.087437 1:STN:280:DC%2BD28rmsVartg%3D%3D 16990356 (Pubitemid 44521172)
30. W.M. Abuhammour R.A. Hasan A. Eljamal B. Asmar 2005 Kawasaki disease hospitalizations in a predominantly African-American population Clin Pediatr 44 721 725 10.1177/000992280504400812 (Pubitemid 41513011)
31. A.R. Porcalla C.A. Sable K.M. Patel, et al. 2005 The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms? Pediatr Cardiol 26 775 781 10.1007/s00246-005-0916-5 1:STN:280:DC%2BD28%2FjsVGiuw%3D%3D 16421770 (Pubitemid 43130169)
32. J. Marquez O. Gedalia L. Candia, et al. 2007 Kawasaki disease: clinical spectrum of 88 patients in a high prevalence African American population J Natl Med Assoc 100 28 32
33. R.E. Kavey V. Allada S.R. Daniels, et al. 2006 Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the AHA expert panel on population and prevention science Circulation 114 2710 2738 10.1161/CIRCULATIONAHA.106.179568 17130340 (Pubitemid 46015982)
34. A. Hata Y. Onouchi 2009 Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine J Hum Genet 54 67 73 10.1038/jhg.2008.9 1:CAS:528:DC%2BD1MXktFClsLw%3D 19158812
35. N. Dahdah A. Siles A. Fournier, et al. 2009 Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki Disease Pediatr Cardiol 30 810 817 10.1007/s00246-009-9441-2 19365652
36. Y. Inoue Y. Okada M. Shinohara, et al. 2006 Multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome J Pediatr 149 336 341 10.1016/j.jpeds.2006.05.025 1:CAS:528:DC%2BD28XovVSrtbc%3D 16939743 (Pubitemid 44308435)
37. J.W. Newburger L.A. Sleeper B.W. McCrindle, et al. 2007 Randomized trial of pulsed corticosteroids therapy for primary for treatment of Kawasaki disease N Engl J Med 356 663 675 10.1056/NEJMoa061235 1:CAS:528:DC%2BD2sXhslegtL4%3D 17301297 (Pubitemid 46257229)
38. J.C. Burns B.M. Best A. Mejias, et al. 2008 Infliximab treatment for intravenous immunoglobulin-resistant Kawasaki disease J Pediatr 153 833 838 10.1016/j.jpeds.2008.06.011 1:CAS:528:DC%2BD1cXhtlyit7bP 18672254
39. K. Hirono Y. Kemmotsu H. Wittkowski, et al. 2009 Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in with refractory Kawasaki Disease Pediatr Res 65 696 701 10.1203/PDR.0b013e31819ed68d 1:CAS:528:DC%2BD1MXlvV2mtL8%3D 19430379
40. R.J. Brogan D. Eleftheriou J. Gnanapragasam, et al. 2009 Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report BMC Pediatr Rheumatol 7 3 10.1186/1546-0096-7-3
41. F. Yalçinkaya Z.B. Ozçakar O. Kasapçopur, et al. 2007 Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa J Pediatr 151 675 678 10.1016/j.jpeds.2007.04.062 18035151 (Pubitemid 350116122)
42. F. Dedeoglu R.P. Sundel 2007 Vasculitis in children Rheum Dis Clin N Am 33 555 583 10.1016/j.rdc.2007.07.007 (Pubitemid 47532352)
43. S.W. de Kort M.A. van Rossum C.R. ten Juvy 2006 Infliximab in a child with therapy-resistant systemic vasculitis Clin Rheumatol 25 769 771 10.1007/s10067-005-0071-7 16267606 (Pubitemid 44111331)
44. K. Sonomoto T. Miyamura H. Watanabe, et al. 2008 A case of polyarteritis nodosa successfully treated by rituximab [in Japanese] Nihon Rinsho Meneki Gakkai Kaishi 31 119 123 18446015
45. S. Ozen A. Bakkaloglu R. Dusunsel, et al. 2007 Turkish Pediatric Vasculitis Study Group: childhood vasculitides in Turkey: a nationwide survey Clin Rheumatol 26 196 200 16586044
46. S. Al Abrawi M. Fouillet-Desjonqueres L. David, et al. 2008 Takayasu arteritis in children Pediatr Rheumatol Online 6 17 10.1186/1546-0096-6-17
47. N. Cakar F. Yalcinkaya A. Duzova, et al. 2008 Takayasu's arteritis in children J Rheumatol 35 913 919 18381778
48. V.P. Aluquin S.A. Albano F. Chan, et al. 2002 Magnetic resonance imaging in the diagnosis and follow up of Takayasu arteritis in children Ann Rheum Dis 61 526 529 10.1136/ard.61.6.526 1:STN:280:DC%2BD383ms1CqsA%3D%3D 12006326 (Pubitemid 34539097)
49. A.K. Shetty A.R. Stopa A. Gedalia 1998 Low dose methotrexate as a steroid-sparing agent in a child with Takayasu arteritis Clin Exp Rheumatol 16 335 336 1:STN:280:DyaK1c3psFamtw%3D%3D 9631760
50. G. Filocamo A. Buoncompagni S. Viola, et al. 2008 Treatment of Takayasu's arteritis with tumor necrosis factor antagonists J Pediatr 153 432 434 10.1016/j.jpeds.2008.04.049 1:CAS:528:DC%2BD1cXhtVahurrM 18718263
51. J. Elbers S.M. Benseler 2008 Central nervous system vasculitis in children Curr Opin Rheumatol 20 47 54 10.1097/BOR.0b013e3282f3177a 18281857 (Pubitemid 351339431)
52. S. Cantez S. Benseler 2008 Childhood CNS vasculitis: a treatable cause of neurological deficit in children Nat Clin Pract Rheumatol 4 460 461 10.1038/ncprheum0860 18628728